 |
 |
|
17 May 2005 | Volume 142 Issue 10 | Pages 855-860
This statement summarizes the U.S. Preventive Services Task Force recommendations on hormone therapy for the prevention of chronic conditions in postmenopausal women and the supporting scientific evidence, and updates the Task Force's 2002 recommendations on hormone replacement therapy. The updated statement is based on the results of the Women's Health Initiative randomized, controlled trial, as well as the information in the 2002 summary of the evidence on this topic, which is available on the USPSTF Web site (http://www.preventiveservices.ahrq.gov).
*For a list of the members of the U.S. Preventive Services Task Force, see the Appendix.
Author and Article Information
From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Requests for Single Reprints: Reprints are available from the USPSTF Web site (http://www.preventiveservices.ahrq.gov) and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295). CLINICAL GUIDELINES
Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women: Recommendations from the U.S. Preventive Services Task Force
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  K. A. Martin and J. E. Manson Approach to the Patient with Menopausal Symptoms J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4567 - 4575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Pettee, K. L. Storti, M. B. Conroy, and B. E. Ainsworth A Lifestyle Approach for Primary Cardiovascular Disease Prevention in Perimenopausal to Early Postmenopausal Women American Journal of Lifestyle Medicine, September 1, 2008; 2(5): 421 - 431. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Heiss, R. Wallace, G. L. Anderson, A. Aragaki, S. A. A. Beresford, R. Brzyski, R. T. Chlebowski, M. Gass, A. LaCroix, J. E. Manson, et al. Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin JAMA, March 5, 2008; 299(9): 1036 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Hadji Menopausal symptoms and adjuvant therapy-associated adverse events Endocr. Relat. Cancer, March 1, 2008; 15(1): 73 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Greiser, E. M. Greiser, and M. Doren Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis Hum. Reprod. Update, September 1, 2007; 13(5): 453 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Manson and S. S. Bassuk Invited Commentary: Hormone Therapy and Risk of Coronary Heart Disease Why Renew the Focus on the Early Years of Menopause? Am. J. Epidemiol., September 1, 2007; 166(5): 511 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Rossouw, R. L. Prentice, J. E. Manson, L. Wu, D. Barad, V. M. Barnabei, M. Ko, A. Z. LaCroix, K. L. Margolis, and M. L. Stefanick Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause JAMA, April 4, 2007; 297(13): 1465 - 1477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Irby, W. F. Anderson, D. E. Henson, and S. S. Devesa Emerging and widening colorectal carcinoma disparities between blacks and whites in the United States (1975-2002). Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 792 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W. Pinn Research on Women's Health: Progress and Opportunities JAMA, September 21, 2005; 294(11): 1407 - 1410. [Full Text] [PDF]
|
|
|
|
|
|
Endocrinology & Metabolism News, July 2005 J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 17a - 17a. [Full Text] [PDF]
|
|
|
|
 |
|
 USPSTF Recommends Against Hormone Therapy to Prevent Chronic Conditions Journal Watch (General), June 14, 2005; 2005(614): 1 - 1. [Full Text]
|
|
Article
